Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 12,494 | 10,302 | 7,352 | 7,483 | 6,882 |
| Operating Income | -12,494 | -10,302 | -7,352 | -7,483 | -6,882 |
| Other Income | 71 | 98 | 137 | 233 | 260 |
| Pre-tax Income | -12,423 | -10,204 | -7,215 | -7,250 | -6,622 |
| Net Income Continuous | -12,423 | -10,204 | -7,215 | -7,250 | -6,622 |
| Net Income | $-12,423 | $-10,204 | $-7,215 | $-7,250 | $-6,622 |
| EPS Basic Total Ops | -2.88 | -2.36 | -17.24 | -41.28 | -37.72 |
| EPS Basic Continuous Ops | -2.86 | -2.37 | -8.26 | -41.29 | -37.70 |
| EPS Diluted Total Ops | -2.88 | -2.36 | -17.24 | -41.28 | -37.72 |
| EPS Diluted Continuous Ops | -2.86 | -2.37 | -8.26 | -41.29 | -37.70 |
| EBITDA(a) | $-12,518 | $-10,290 | $-7,323 | $-7,471 | $-6,882 |